NovMetaPharma Market Cap

NovMetaPharma has a market cap or net worth of 121.99 billion as of April 24, 2026. Its market cap has increased by 9.62% in one year.

Market Cap

121.99B

Enterprise Value

n/a

Revenue

1.30B

Ranking

n/a

PE Ratio

79.17

Stock Price

9,390.00

Market Cap Chart

Since April 5, 2017, NovMetaPharma's market cap has increased from 74.59B to 121.99B, an increase of 63.55%. That is a compound annual growth rate of 5.58%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2026	121.99B	-25.47%
Dec 30, 2025	163.69B	187.16%
Dec 30, 2024	57.00B	-46.33%
Dec 29, 2022	106.21B	-45.89%
Dec 30, 2021	196.29B	-9.50%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
QuadMedicine	149.50B
CORESTEMCHEMON	144.17B
BIO-FD&C	125.65B
Cell Biotech	110.12B
TegoScience	102.80B
KoBioLabs	102.73B
CHA Vaccine Research Institute	100.21B
SunBio,Inc.	98.77B

Market Cap Rankings